Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in Friedreich Ataxia
NCT02424435Phase 1Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of methylprednisolone in Friedreich ataxia (FA), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Timed 25 Foot Walk at 26 weeks. Started Jun 2015; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT02424435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424435.